Zolmitriptan indications and usage

Zolmitriptan
ZOLMITRIPTAN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Zolmitriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Indications and Usage

Zolmitriptan orally disintegrating tabletsare indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use

• Only use zolmitriptan orally disintegrating tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan orally disintegrating tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan orally disintegrating tablets are administered to treat any subsequent attacks.

• Zolmitriptan orally disintegrating tablets are not indicated for the prevention of migraine attacks.

• Safety and effectiveness of zolmitriptan orally disintegrating tablets have not been established for cluster headache.

References

Adapted from the FDA Package Insert.